miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I

被引：49

作者：

Song, Bin ^{[1
]}

Ji, Weiping ^{[1
]}

Gu, Shiwei ^{[1
]}

Liu, Anan ^{[1
]}

Jing, Wei ^{[1
]}

Shao, Chenghao ^{[1
]}

Li, Gang ^{[1
]}

Jin, Gang ^{[1
]}

机构：

[1] Second Mil Med Univ, Dept Pancreat Surg, Changhai Hosp, Shanghai 200082, Peoples R China

来源：

FEBS LETTERS | 2014年 / 588卷 / 23期

基金：

上海市自然科学基金;

关键词：

miR-545; Pancreatic ductal adenocarcinoma; RIG-I; Patients survival; Cancer growth; HEPATOCELLULAR-CARCINOMA; MICRORNAS; CANCER; RECOGNITION; SURVIVAL; RNA; ACTIVATION; APOPTOSIS; GENES; CELLS;

D O I：

10.1016/j.febslet.2014.10.004

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) ranks fourth on the list of cancer-related causes of death. Deregulation or dysfunction of miRNAs contribute to cancer development. In this study, we found that low miR-545 level and high RIG-I protein in PDAC tissues were both correlated with low survival rate. MiR-545 up-regulation inhibited PDAC cell lines growth and vice versa. 3'UTR of RIG-I was targeted by miR-545. Thus we concluded that low miR-545 levels in PDAC promote tumor cells growth, and this is associated with reduced survival in PDAC patients. MiR-545 exerts its effects by directly targeting RIG-1. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：4375 / 4381

页数：7

共 50 条

[21] Targeting mTOR in Pancreatic Ductal Adenocarcinoma
Iriana, Sentia
Ahmed, Shahzad
Gong, Jun
Annamalai, Alagappan Anand
Tuli, Richard
Hendifar, Andrew Eugene
FRONTIERS IN ONCOLOGY, 2016, 6
[22] ZNF205 positively regulates RLR antiviral signaling by targeting RIG-I
Zhong, Ni
Wang, Chen
Weng, Guangxiu
Ling, Ting
Xu, Liangguo
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (10) : 1582 - 1591
[23] miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2
Lu, Huimin
Zhang, Ling
Lu, Shan
Yang, Dujiang
Ye, Jun
Li, Mao
Hu, Weiming
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (05) : 3384 - 3390
[24] Targeting RIG-I or STING promotes epithelial regeneration
Fischer, Julius C.
Poeck, Hendrik
ONCOTARGET, 2017, 8 (70) : 114418 - 114419
[25] RNF135 is a positive regulator of IFN expression and involved in RIG-I signaling pathway by targeting RIG-I
Lai, Yuxiong
Liang, Min
Hu, La
Zeng, Zicheng
Lin, Hai
Yi, Gao
Li, Ming
Liu, Zhaoyu
FISH & SHELLFISH IMMUNOLOGY, 2019, 86 : 474 - 479
[26] MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma
Zhu, Weihua
Wang, Yazhou
Zhang, Dafang
Yu, Xin
Leng, Xisheng
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (04) : 963 - 970
[27] Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy
Zhang, Yi-Fan
Jiang, Shu-Heng
Hu, Li-Peng
Huang, Pei-Qi
Wang, Xu
Li, Jun
Zhang, Xue-Li
Nie, Hui-Zhen
Zhang, Zhi-Gang
CHINESE CLINICAL ONCOLOGY, 2019, 8 (02)
[28] miR-337 regulates the proliferation and invasion in pancreatic ductal adenocarcinoma by targeting HOXB7
Zhang, Rui
Leng, Hong
Huang, Junwen
Du, Yuwen
Wang, Yuanyuan
Zang, Wenqiao
Chen, Xiaonan
Zhao, Guoqiang
DIAGNOSTIC PATHOLOGY, 2014, 9
[29] MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt
Yang, Wenzhuo
Yang, Yanning
Xia, Lu
Yang, Yuefeng
Wang, Fei
Song, Meiyi
Chen, Xiaoyu
Liu, Jingqi
Song, Yang
Zhao, Yingying
Yang, Changqing
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (06) : 2366 - 2374
[30] CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma
Gao, Xiaohua
Deeb, Dorrah
Liu, Yongbo
Liu, Patricia
Zhang, Yiguan
Shaw, Jiajiu
Gautam, Subhash C.
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (06) : 2100 - 2106

← 1 2 3 4 5 →